Cambridge Isotope Laboratories, Inc.

Cambridge Isotope Laboratories, Inc. Leading producer of stable isotopes & isotope-labeled compounds. Enriching Scientific Discovery® since 1981.

Join us in advancing research & innovation!

Could your synthetic route benefit from an efficient approach to site-specific deuterium incorporation?Process chemists ...
09/04/2026

Could your synthetic route benefit from an efficient approach to site-specific deuterium incorporation?

Process chemists developing deuterated APIs are often challenged to achieve selective deuterium incorporation while maintaining process efficiency and synthetic flexibility.

-d₃ has become an important reagent for site-specific deuterium incorporation through selective reduction chemistry, enabling streamlined preparation of deuterated intermediates and APIs.

As deuterated drug programs move toward clinical and commercial stages, project teams increasingly evaluate factors beyond reaction performance.
• Supply chain reliability
• Manufacturing scalability
• Regulatory readiness
• Long-term availability
These considerations can significantly influence development timelines and commercialization strategies.

At CIL, we believe deuterated reagents should not only support successful chemistry, but also successful scale-up.

📍 Meet our team at - CIL BOOTH 3F34, to discuss how ISOAPI-D™ can support your next generation of deuterated therapeutics.

For more information: https://technologies.isotope.com/

Heading to SMASH 2026? Be sure to stop by and say hello to CIL!Join us in Breckenridge, CO, September 13-16 to learn mor...
09/03/2026

Heading to SMASH 2026? Be sure to stop by and say hello to CIL!

Join us in Breckenridge, CO, September 13-16 to learn more about how CIL’s stable isotope products can support your NMR and biomolecular research. From deuterated solvents and biomolecular substrates to cell growth media, protein standards, and more, we’ll have plenty to talk about!

We look forward to seeing you at SMASH 2026!

For more information: https://smashnmr.org/

Register Today for the first of our 4-part webinar series Isotope Days 2026: Mass SpectrometrySeptember 22, 2026 | 10:00...
09/01/2026

Register Today for the first of our 4-part webinar series Isotope Days 2026: Mass Spectrometry

September 22, 2026 | 10:00-11:30 AM (EDT)

We’re excited to announce the start of this year’s Isotope Days Webinar Series, where leading researchers share the latest breakthroughs in isotope-enabled science!

Meet our speakers:

Ralph DeBerardinis, PhD – Professor and Director at the Eugene McDermott Center for Human Growth and Development, UT Southwestern (USA)

Talk: Stable Isotope Tracing to Identify Metabolic Preferences and Liabilities in Cancer

Dr. DeBerardinis will reveal how stable isotope tracing uncovers the metabolic strategies that drive cancer progression, metastasis, and therapy resistance.

Gary Patti, PhD – Professor of Chemistry, Genetics, and Medicine at Washington University in St. Louis (USA)

Talk: Isotopes at the Nexus of Metabolism Research

Dr. Patti will explore the pivotal role of isotopes in mapping and understanding metabolism, highlighting their impact on biomedical research.

Timon Geib, PhD – Research Associate at the Lady Davis Institute for Medical Research (Canada)

Talk: Cost-Effective and Comprehensive Tissue-Specific Absolute Quantification Using SysQuan

Dr. Geib presents a powerful approach for absolute quantification in tissues, making advanced isotope-based analysis more accessible and comprehensive than ever.

Join us and discover how stable isotopes are transforming science and medicine.

Learn more and register: https://cil.isotope.com/acton/fs/blocks/showLandingPage/a/8794/p/p-0149/t/page/fm/2

How do you efficiently introduce a deuterated methylamino group into your synthetic route?For many deuterated drug devel...
08/27/2026

How do you efficiently introduce a deuterated methylamino group into your synthetic route?

For many deuterated drug development programs, site-specific incorporation of a deuterated methylamino group represents an important strategy for achieving targeted deuterium incorporation at metabolically relevant positions.
Methylamine-d₃ serves as a versatile building block for the synthesis of a wide range of pharmaceutical intermediates and active ingredients. By enabling direct introduction of an N-CD₃ group, it provides an efficient pathway toward highly enriched deuterated compounds and supports medicinal chemistry efforts aimed at improving metabolic stability.
As development programs advance, the discussion quickly moves beyond chemistry.
• Can supply support future scale-up?
• Is material available beyond laboratory quantities?
• Can long-term supply be secured?

These questions become increasingly important as projects move from discovery into process development, clinical manufacturing, and ultimately commercialization.
As part of the ISOAPI-D™ portfolio, Methylamine-d₃ is supported by CIL's extensive expertise in deuterated materials and scalable manufacturing capabilities, helping customers secure a reliable supply of critical deuterated building blocks throughout the product lifecycle.

📍 Visiting this October? Let's discuss your deuterated API development and manufacturing challenges. CIL BOOTH 3F34

For more information: https://technologies.isotope.com/

CIL’s environmental reference standards team will be in Riva del Garda for DIOXIN/BFR 2026 and is excited to continue di...
08/26/2026

CIL’s environmental reference standards team will be in Riva del Garda for DIOXIN/BFR 2026 and is excited to continue discussions with researchers from around the world. Stop by Booth #25 to connect with us and learn more about our expanding selection of stable isotope-labeled and unlabeled analytical standards for environmental, food, water, and biomonitoring analysis.

To learn more about DIOXIN: https://dioxin2026.org/

We look forward to many great discussions with you in Italy!

Are you preparing for commercial-scale deuterated API manufacturing early enough?The success of a deuterated drug progra...
08/20/2026

Are you preparing for commercial-scale deuterated API manufacturing early enough?

The success of a deuterated drug program can create an unexpected challenge.

A process that consumes grams of material in discovery may require kilograms during clinical development and eventually hundreds of kilograms after commercial launch.

Yet sourcing strategies often remain focused on the immediate needs of development.

The reality is that commercialization begins long before approval.

Supply security, scalability, quality systems, and access to critical deuterated starting materials all play an important role in the journey from concept to commercial product.

At CIL, we are seeing growing interest from pharmaceutical companies and CDMOs looking beyond laboratory quantities and thinking strategically about long-term manufacturing readiness.

Over the coming weeks, we'll be highlighting several key ISOAPI-D™ reagents that support the development and manufacturing of next-generation deuterated APIs.

📍 Meet our team at CPHI Milan - BOOTH 3F34, and let's discuss how to build a secure foundation for your deuterated API programs.

For more information: https://technologies.isotope.com/

-D

CIL is heading to ICMRBS 2026 in Davos, Switzerland!We’re proud to sponsor this year’s meeting and are excited to be joi...
08/17/2026

CIL is heading to ICMRBS 2026 in Davos, Switzerland!

We’re proud to sponsor this year’s meeting and are excited to be joined by our colleagues from Eurisotop. Stop by our booth to connect with the team and learn more about CIL’s stable isotope-labeled products for NMR and magnetic resonance research.

Whether you’re looking for a specific isotopically labeled compound or exploring solutions for your latest research, our team will be there to talk about how CIL can support your work.

We look forward to seeing you in Davos!

For more information about ICMRBS: https://icmrbs2026.org/

Cambridge Isotope Laboratories, Inc. (CIL) is proud to announce that our R&D, Research Products, and Formulations labora...
08/05/2026

Cambridge Isotope Laboratories, Inc. (CIL) is proud to announce that our R&D, Research Products, and Formulations laboratories have achieved My Green Lab® Certification at the Platinum level. Our Solvents laboratory has also earned Gold Level certification.
My Green Lab Certification is recognized worldwide as a benchmark for sustainable laboratory practices. We joined this program to make meaningful changes that reduce the environmental impact of our research and production. These certifications highlight CIL’s dedication to measurable, science-driven improvements in lab operations and sustainability.
By earning this certification, our labs join a global community of thousands committed to advancing sustainability in scientific research. Together, we’re shaping a more sustainable future for science.
You can learn more about the program and what it means to be My Green Lab Certified at mygreenlab.org/programs/mgl-certification

https://isotope.com/environmental-sustainability

Heading to the Rocky Mountain Conference on Magnetic Resonance (RMCMR) 2026? Stop by Booth  #9 and connect with the Camb...
07/28/2026

Heading to the Rocky Mountain Conference on Magnetic Resonance (RMCMR) 2026? Stop by Booth #9 and connect with the Cambridge Isotope Labs team! Learn about our latest isotopic solutions for NMR research, explore our product offerings, and chat with us about how we can support your work.

We look forward to seeing you in Snowbird!

For more information about RMCMR: https://rockychem.com/

Catch up with CIL at EMS in Houston! CIL is excited to be exhibiting at the Environmental Measurement Symposium (EMS) in...
07/20/2026

Catch up with CIL at EMS in Houston!

CIL is excited to be exhibiting at the Environmental Measurement Symposium (EMS) in Houston, TX! Stop by Booth #32 from August 3-5 to connect with Ben Priest and Dawn Mantz and explore the latest updates to CIL’s environmental standards product line. We have lots of exciting new releases to share, including standards for terminal and precursor PFAS compounds, new ultrashort-chain PFAS, enhanced Method 1633A mixtures, new PPD analogs for tire-wear studies, and much more!

We look forward to seeing you and discussing how CIL’s standards can help support your environmental testing and research!

For more information about EMS 2026: https://envirosymposium.group/meeting/2026/confinfo.php?ap3=1_1

Address

3 Highwood Drive
Tewksbury, MA
01876

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+19787498000

Alerts

Be the first to know and let us send you an email when Cambridge Isotope Laboratories, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Cambridge Isotope Laboratories, Inc.:

Shortcuts

Share